These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7911876)

  • 21. [The immune response in HIV infection and associated diseases of the female genitalia].
    Lakatosh VP; Lazarenko LN; Spivak NIa; Lianenko LA
    Lik Sprava; 1998; (7):25-36. PubMed ID: 10050451
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of glucocorticosteroids on the immunological indices of diffuse toxic goiter patients].
    Epishin AV
    Vrach Delo; 1984 Jul; (7):41-3. PubMed ID: 6332424
    [No Abstract]   [Full Text] [Related]  

  • 23. Dendritic cells and HIV infection; immunity with viral transmission versus compromised cellular immunity?
    Knight SC
    Immunobiology; 2001 Dec; 204(5):614-21. PubMed ID: 11846226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An HIV vaccine--evolving concepts.
    Johnston MI; Fauci AS
    N Engl J Med; 2007 May; 356(20):2073-81. PubMed ID: 17507706
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospects for immune reconstitution in HIV-1 infection.
    Imami N; Gotch F
    Clin Exp Immunol; 2002 Mar; 127(3):402-11. PubMed ID: 11966755
    [No Abstract]   [Full Text] [Related]  

  • 26. Interleukin-7 and immunorestoration in HIV: beyond the thymus.
    Fry TJ; Mackall CL
    J Hematother Stem Cell Res; 2002 Oct; 11(5):803-7. PubMed ID: 12427286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal steroidogenesis and congenital adrenal hyperplasia.
    Turcu AF; Auchus RJ
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):275-96. PubMed ID: 26038201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection.
    Jones T
    Curr Opin Investig Drugs; 2010 Aug; 11(8):964-70. PubMed ID: 20721838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HIV infection. The biological mechanism].
    Boschini A
    Riv Odontoiatr Amici Brugg; 1990; 9(4):25-8, 30-2. PubMed ID: 2095462
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunopathological mechanisms of HIV infection].
    Gluckman JC
    Rev Med Interne; 1995; 16 Suppl 3():303s-307s. PubMed ID: 8570968
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors.
    Tamarit A; Alberola J; Mira JV; Tornero C; Galindo MJ; Navarro D
    J Med Virol; 2004 Nov; 74(3):382-9. PubMed ID: 15368523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV.
    Rook GA; Onyebujoh P; Stanford JL
    Immunol Today; 1993 Nov; 14(11):568-9. PubMed ID: 7903855
    [No Abstract]   [Full Text] [Related]  

  • 34. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytokine therapies in HIV infection].
    Lévy Y
    Med Sci (Paris); 2006; 22(8-9):751-4. PubMed ID: 16962051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current topics in HIV-1 pathogenesis: The emergence of deregulated immuno-metabolism in HIV-infected subjects.
    Dagenais-Lussier X; Mouna A; Routy JP; Tremblay C; Sekaly RP; El-Far M; Grevenynghe Jv
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):603-13. PubMed ID: 26409789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What's new in HIV/AIDS. Protective immunity in HIV infection: where do we stand?
    Draenert R; Goebel FD
    Infection; 2004 Aug; 32(4):250-2. PubMed ID: 15293085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ T lymphocytes producing Th2-type cytokines (Tc2) in HIV-infected individuals.
    Maggi E; Manetti R; Annunziato F; Romagnani S
    J Biol Regul Homeost Agents; 1995; 9(3):78-81. PubMed ID: 8782011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis, natural history, and classification of HIV infection.
    Libman H
    Prim Care; 1992 Mar; 19(1):1-17. PubMed ID: 1594691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients.
    Jaleco AC; Covas MJ; Victorino RM
    Clin Exp Immunol; 1994 Nov; 98(2):185-9. PubMed ID: 7955520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.